• Pivotal bioVenture Partners China, a member of Nan Fung Life Sciences, is a venture capital fund investing in privately held companies in Great China region, seeking companies with innovative therapeutic products and platforms that address major, unmet medical needs. • Our investment strategy is centered on identifying promising innovative products and technologies to serve the growing unmet medical needs in Greater China region via company building and investment. We are dedicated to bringing together talented teams and innovative products, enabling our portfolio companies to pursue big missions. • The Pivotal China team includes experienced life science investors and entrepreneurs with successful track records of venture building and investing.